"I'm also very excited about ophthalmology because, as you know, that is one of the areas I love from my Bausch and Lomb days. And I think there is more upside in ophthalmology than people realize. It really has become a two player game with Alcon and Allergan, and I think Allergan has a really strong opportunity to take market share in ophthalmology."
--Brent Saunders, CEO Actavis, speaking at the Goldman Sach's Unscripted Healthcare Conference, January 5, 2015
--Brent Saunders, CEO Actavis, speaking at the Goldman Sach's Unscripted Healthcare Conference, January 5, 2015
Take that, Valeant! Trash talk from Brent Saunders to Michael Pearson
Aucun commentaire:
Enregistrer un commentaire